Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|5|5|459-470

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.5, Iss.5, 2004-10, pp. : 459-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

By Smith H.J.   Nicholls P.J.   Simons C.   Lain R.L.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 789-824

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease

By  

Current Molecular Pharmacology, Vol. 9, Iss. 2, 2015-12 ,pp. : 109-125

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 Polymorphisms as Risk Factors for Steroid Hormone-Related Cancers

By Friedberg T.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Search for Potential Non-Steroidal Inhibitors of 17 &bgr;-Hydroxysteroid Dehydrogenase (17 &bgr;-HSD) in the Treatment of Hormone-Dependent Cancers

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 3, 2007-04 ,pp. : 180-184

Bentham Science Publishers

Access to resources Recommend Favorite

Opportunities for development of novel therapies targeting steroid hormone receptors

By Bai Chang   Flores Osvaldo   Schmidt Azriel  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 725-737

Informa Healthcare

Access to resources Recommend Favorite